Nykode Therapeutics AS Statistics
Total Valuation
VACBF has a market cap or net worth of 133.03 million. The enterprise value is 69.09 million.
| Market Cap | 133.03M |
| Enterprise Value | 69.09M |
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 326.55M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -22.32% |
| Shares Change (QoQ) | +12.08% |
| Owned by Insiders (%) | 14.95% |
| Owned by Institutions (%) | 31.59% |
| Float | 159.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.11 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.28 |
| EV / Sales | 8.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.93 |
Financial Position
The company has a current ratio of 17.14, with a Debt / Equity ratio of 0.03.
| Current Ratio | 17.14 |
| Quick Ratio | 17.14 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -191.94 |
Financial Efficiency
Return on equity (ROE) is -9.10% and return on invested capital (ROIC) is -71.49%.
| Return on Equity (ROE) | -9.10% |
| Return on Assets (ROA) | -12.08% |
| Return on Invested Capital (ROIC) | -71.49% |
| Return on Capital Employed (ROCE) | -26.02% |
| Weighted Average Cost of Capital (WACC) | 10.75% |
| Revenue Per Employee | 118,484 |
| Profits Per Employee | -177,452 |
| Employee Count | 62 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.81% in the last 52 weeks. The beta is 1.21, so VACBF's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +57.81% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 36.88 |
| Average Volume (20 Days) | 3,099 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, VACBF had revenue of 7.35 million and -11.00 million in losses. Loss per share was -0.04.
| Revenue | 7.35M |
| Gross Profit | 7.35M |
| Operating Income | -26.49M |
| Pretax Income | -16.64M |
| Net Income | -11.00M |
| EBITDA | -25.75M |
| EBIT | -26.49M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 63.93 million in cash and 2.90 million in debt, with a net cash position of 61.03 million.
| Cash & Cash Equivalents | 63.93M |
| Total Debt | 2.90M |
| Net Cash | 61.03M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 99.25M |
| Book Value Per Share | 0.30 |
| Working Capital | 63.03M |
Cash Flow
In the last 12 months, operating cash flow was -35.69 million and capital expenditures -87,000, giving a free cash flow of -35.77 million.
| Operating Cash Flow | -35.69M |
| Capital Expenditures | -87,000 |
| Free Cash Flow | -35.77M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -360.58% and -149.77%.
| Gross Margin | 100.00% |
| Operating Margin | -360.58% |
| Pretax Margin | -226.52% |
| Profit Margin | -149.77% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VACBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 22.32% |
| Shareholder Yield | 22.32% |
| Earnings Yield | -8.27% |
| FCF Yield | -26.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VACBF has an Altman Z-Score of 6.95 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.95 |
| Piotroski F-Score | 2 |